Home LiteratureArticle Details
PMID: 10848607 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation.

Molecular and cellular biology ·Vol. 20 ·No. 13 ·2000-07-00 ·Pages 4814-25

Falvo JV, Parekh BS, Lin CH, Fraenkel E, Maniatis T

Abstract

Heterodimeric transcription factors, including the basic region-leucine zipper (bZIP) protein ATF-2-c-jun, are well-characterized components of an enhanceosome that mediates virus induction of the human beta interferon (IFN-beta) gene. Here we report that within the IFN-beta enhanceosome the ATF-2-c-jun heterodimer binds in a specific orientation, which is required for assembly of a complex between ATF-2-c-jun and interferon regulatory factor 3 (IRF-3). We demonstrate that correct orientation of the ATF-2-c-jun binding site is required for virus induction of the IFN-beta gene and for IRF-3-dependent activation of a composite ATF-2- c-jun-IRF site in the IFN-beta promoter. We also show that in vitro the DNA-bound ATF-2-c-jun heterodimer adopts a fixed orientation upon the binding of IRF-3 at an adjacent site in the IFN-beta enhancer and that the DNA-binding domain of IRF-3 is sufficient to mediate this effect. In addition, we show that the DNA-binding domain of ATF-2 is necessary and sufficient for selective protein-protein interactions with IRF-3. Strikingly, in vivo chromatin immunoprecipitation experiments with IFN-beta reporter constructs reveal that recruitment of IRF-3 to the IFN-beta promoter upon virus infection is dependent on the orientation of the ATF-2-c-jun heterodimer binding site. These observations demonstrate functional and physical cooperativity between the bZIP and IRF transcription factor families and illustrate the critical role of heterodimeric transcription factors in formation of the IFN-beta enhanceosome.

MeSH Terms
Activating Transcription Factor 2 Amino Acid Sequence Base Sequence Binding Sites Cross-Linking Reagents Cyclic AMP Response Element-Binding Protein/metabolism DNA/metabolism DNA-Binding Proteins/metabolism Dimerization Enhancer Elements, Genetic Glutathione Transferase/genetics,metabolism HeLa Cells/virology Humans Interferon Regulatory Factor-1 Interferon Regulatory Factor-2 Interferon Regulatory Factor-3 Interferon-beta/genetics,metabolism Leucine Zippers Molecular Sequence Data Mutagenesis, Site-Directed Phosphoproteins/metabolism Promoter Regions, Genetic Proto-Oncogene Proteins c-jun/metabolism Recombinant Proteins/genetics,metabolism Regulatory Sequences, Nucleic Acid Repressor Proteins Response Elements Transcription Factors/metabolism
Chemicals
ATF2 protein, human Activating Transcription Factor 2 Cross-Linking Reagents Cyclic AMP Response Element-Binding Protein DNA-Binding Proteins IRF1 protein, human IRF2 protein, human IRF3 protein, human Interferon Regulatory Factor-1 Interferon Regulatory Factor-2 Interferon Regulatory Factor-3 Phosphoproteins Proto-Oncogene Proteins c-jun Recombinant Proteins Repressor Proteins Transcription Factors Interferon-beta DNA Glutathione Transferase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Falvo J V
Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.
Parekh B S
Lin C H
Fraenkel E
Maniatis T
References (63)
63 references, click to expand
  1. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.
    Mol Cell Biol. 1998 May;18(5):2986-96 PMID: 9566918
  2. Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences.
    EMBO J. 1999 Sep 15;18(18):5028-41 PMID: 10487755
  3. Molecular basis of cooperative DNA bending and oriented heterodimer binding in the NFAT1-Fos-Jun-ARRE2 complex.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7915-20 PMID: 9653115
  4. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.
    Mol Cell. 1997 Dec;1(1):119-29 PMID: 9659909
  5. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.
    Mol Cell. 1998 Jan;1(2):277-87 PMID: 9659924
  6. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.
    Mol Cell. 1998 Mar;1(4):507-18 PMID: 9660935
  7. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro.
    Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12191-6 PMID: 9770462
  8. DNA bending determines Fos-Jun heterodimer orientation.
    Nat Struct Biol. 1998 Oct;5(10):877-81 PMID: 9783746
  9. The orientation of the AP-1 heterodimer on DNA strongly affects transcriptional potency.
    Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14076-81 PMID: 9826656
  10. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
    EMBO J. 1999 Feb 15;18(4):977-91 PMID: 10022840
  11. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter.
    Mol Cell. 1999 Jan;3(1):125-9 PMID: 10024886
  12. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2740-5 PMID: 10077581
  13. Transcription activation by the adenovirus E1a protein.
    Nature. 1989 Mar 2;338(6210):39-44 PMID: 2521923
  14. Association of nuclear oncoproteins fos and jun.
    Curr Opin Cell Biol. 1989 Jun;1(3):536-40 PMID: 2516738
  15. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.
    Science. 1990 Sep 14;249(4974):1266-72 PMID: 2119054
  16. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.
    Cell. 1990 Oct 19;63(2):303-12 PMID: 2208287
  17. Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation.
    Ann N Y Acad Sci. 1990;599:1-11 PMID: 2171390
  18. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Science. 1991 Mar 8;251(4998):1211-7 PMID: 2006410
  19. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3720-4 PMID: 1827203
  20. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions.
    Science. 1991 May 10;252(5007):842-4 PMID: 1827531
  21. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.
    EMBO J. 1991 Jul;10(7):1817-25 PMID: 2050119
  22. An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected].
    Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2150-4 PMID: 1532252
  23. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene.
    Cell. 1992 Nov 27;71(5):777-89 PMID: 1330326
  24. Secreted placental alkaline phosphatase as a eukaryotic reporter gene.
    Methods Enzymol. 1992;216:362-8 PMID: 1479908
  25. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein.
    EMBO J. 1993 Feb;12(2):479-87 PMID: 8382609
  26. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.
    Cell. 1993 Sep 10;74(5):887-98 PMID: 8374955
  27. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization.
    Science. 1993 Oct 15;262(5132):395-9 PMID: 8211160
  28. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    EMBO J. 1993 Sep;12(9):3551-8 PMID: 8253080
  29. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.
    Nature. 1994 Apr 7;368(6471):520-5 PMID: 8139685
  30. Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene.
    J Leukoc Biol. 1994 Jul;56(1):27-35 PMID: 8027667
  31. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation.
    Mol Cell Biol. 1994 Oct;14(10):6570-83 PMID: 7935378
  32. Specific photocrosslinking of DNA-protein complexes: identification of contacts between integration host factor and its target DNA.
    Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12183-7 PMID: 7991603
  33. Identification of the rel family members required for virus induction of the human beta interferon gene.
    Mol Cell Biol. 1995 Jan;15(1):152-64 PMID: 7799921
  34. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation.
    Mol Cell Biol. 1995 Mar;15(3):1154-61 PMID: 7862109
  35. Structural determinants of nuclear receptor assembly on DNA direct repeats.
    Nature. 1995 May 18;375(6528):203-11 PMID: 7746322
  36. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    Oncogene. 1995 Jul 20;11(2):365-76 PMID: 7624151
  37. Only one of the two DNA-bound orientations of AP-1 found in solution cooperates with NFATp.
    Curr Biol. 1995 Aug 1;5(8):882-9 PMID: 7583146
  38. Crystal structure of a bZIP/DNA complex at 2.2 A: determinants of DNA specific recognition.
    J Mol Biol. 1995 Dec 8;254(4):657-67 PMID: 7500340
  39. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.
    Cell. 1995 Dec 29;83(7):1091-100 PMID: 8548797
  40. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y).
    Cell. 1995 Dec 29;83(7):1101-11 PMID: 8548798
  41. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp.
    Mol Cell Biol. 1996 Feb;16(2):459-67 PMID: 8552071
  42. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9358-65 PMID: 8790334
  43. High-resolution mapping of nucleoprotein complexes by site-specific protein-DNA photocrosslinking: organization of the human TBP-TFIIA-TFIIB-DNA quaternary complex.
    Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10620-5 PMID: 8855228
  44. Analysis of chromatin structure by in vivo formaldehyde cross-linking.
    Methods. 1997 Feb;11(2):205-14 PMID: 8993033
  45. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.
    J Biol Chem. 1997 Jan 31;272(5):2753-61 PMID: 9006914
  46. AP-1 function and regulation.
    Curr Opin Cell Biol. 1997 Apr;9(2):240-6 PMID: 9069263
  47. Transcription factors of the NFAT family: regulation and function.
    Annu Rev Immunol. 1997;15:707-47 PMID: 9143705
  48. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter.
    Mol Cell Biol. 1997 Jul;17(7):3649-62 PMID: 9199299
  49. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation.
    Nature. 1998 Jan 1;391(6662):103-6 PMID: 9422515
  50. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.
    Nature. 1998 Jan 22;391(6665):410-3 PMID: 9450761
  51. Regulation of type I interferon gene expression by interferon regulatory factor-3.
    J Biol Chem. 1998 Jan 30;273(5):2714-20 PMID: 9446577
  52. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.
    EMBO J. 1998 Feb 16;17(4):1087-95 PMID: 9463386
  53. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.
    Mol Cell Biol. 1998 Mar;18(3):1359-68 PMID: 9488451
  54. The enhanceosome and transcriptional synergy.
    Cell. 1998 Jan 9;92(1):5-8 PMID: 9489694
  55. Rb interacts with histone deacetylase to repress transcription.
    Cell. 1998 Feb 20;92(4):463-73 PMID: 9491888
  56. Histone acetylation and transcriptional regulatory mechanisms.
    Genes Dev. 1998 Mar 1;12(5):599-606 PMID: 9499396
  57. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA.
    Nature. 1998 Mar 5;392(6671):42-8 PMID: 9510247
  58. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene.
    FEBS Lett. 1998 Mar 20;425(1):112-6 PMID: 9541017
  59. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains.
    Mol Cell Biol. 1999 Apr;19(4):2465-74 PMID: 10082512
  60. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
    EMBO J. 1999 Jun 1;18(11):3074-89 PMID: 10357819
  61. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.
    EMBO J. 1999 Jun 1;18(11):3090-100 PMID: 10357820
  62. Structure and function of the interferon-beta enhanceosome.
    Cold Spring Harb Symp Quant Biol. 1998;63:609-20 PMID: 10384326
  63. Cooperative interaction between the DNA-binding domains of PU.1 and IRF4.
    J Mol Biol. 1998 Jun 26;279(5):1075-83 PMID: 9642085
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2000-07-00
Pages
4814-25
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC85927
Subset
IM
Grants
NIAID NIH HHS · R01 AI020642 · United States
NIAID NIH HHS · AI20642 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]